Beijing Tiantan Biological Products Corporation LimitedSSE: 600161

(600161)"BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD."Announcement on Obtaining the Clinical Study Report by Subordinate Company

· Issued by Beijing Tiantan Biological Products Corporation Limited via Shanghai Stock Exchange

Filed with SSE · Stock code 600161 · · 2 pages · Chinese

Summary by 6ix AI

Beijing Tiantan Biological Products Corporation Limited announced that its subsidiary has obtained a clinical study report for a new product.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600161beijing-tiantan-biological-products-co-ltdannouncement-on-obtaining-the-clinical-study-report-by-subordinate-company

Release

Announcement on Obtaining the Clinical Study Report by Subordinate Company

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Beijing Tiantan Biological Products Corporation Limited on 6ix

Story so far

Earlier from Beijing Tiantan Biological Products

All Beijing Tiantan Biological Products news releases